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Leukaemic blast progenitors of patients with acute
myeloblastic leukaemia (AML) are characterized as stem
cells; they may undergo terminal division and/or renew
themselves (McCulloch et al., 1981). The assay for leukaemic
blast progenitors depends on colony formation in cultures
made viscid in the presence of an appropriate growth factor.
Primary colony forming efficiency (PEI) is considered to
reflect terminal division, whereas secondary colony forming
efficiency (PE2) reflects self-renewal of the blast progenitors.
Self-renewal capacity has been considered as the crucial
biological property of leukaemic blasts, since a highly
significant correlation between PE2 and prognosis has been
found (McCulloch et al., 1981). From this point of view, a
strategy for the treatment of AML may be the elimination of
the self-renewal capacity of the blast progenitors. In order to
establish a theoretical treatment schedule for acute
leukaemia, it is important to determine the effects of anti-
leukaemic agents on both the terminal division and self-
renewal of leukaemic blast progenitors. However, such
effects still remain unclear except for cytosine arabinside
(Ara-C) and adriamycin (ADM) (Buick et al., 1981; Nara et
al., 1986). In the present study, we studied the effects of
vinca alkaloids (vincristin: VCR; vindesine: VDS) and
epipodophyllotoxin (etoposide: VP16), which are mitotic
inhibitors and useful for the treatment of neoplasms (Sauter
et al., 1982; Barlogie et al., 1984; Klimo et al., 1985; Smith
et al., 1983), on the terminal division (PEI) and self-renewal
(PE2) of clonogenic cells of an established cell line, M-3.
Although the question still remains whether the clonogenic
cell of an established cell line are equivalent to the blast
progenitors freshly obtained from AML patients, their high
proliferative property implies a similarity in character with
blast progenitors as stem cells. In this light we thought it
appropriate to utilise the clonogenic cells of such a cell line
as a model for blast progenitors. We also measured the
efficacy of the three drugs, on the normal CFU-C capacity
of RFM mice so as to assess the difference in sensitivity
between leukaemic and normal progenitors.
Cell line (M-3) This cell line, a gift from Dr. Bessho, was
established from a myeloblastic leukaemia of an RFM strain
mouse induced 10 months after 3Gy whole body X-
irradiation. It has been maintained in vitro ever since: 4 to
5 x 105 cells are transplanted twice a week in ax-minimum
essential medium (at-MEM, Gibco, Grand Island, USA) with
20% foetal calf serum (FCS, Gibco). Leukaemic cells were
positive for peroxidase and naphthol ASD chloroacetate
esterase, but negative for periodic acid Schiff (PAS) and
esterase butyrate stain. They possessed marker chromosome
2q-, which is specific for murine myeloblastic leukaemia
(Hayata et al., 1983). These characteristics have remained
unchanged and will be described elsewhere (Maruyama et al.
in preparation).
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Assay for blast colony formation Primary blast colony
formation in culture (PEl) was determined as follows:
Leukaemic cells were plated at a concentration of 5x 103
cellsml-1 in 1 ml a-MEM, supplemented with 0.8%
methylcellulose (4000cps Wako, Osaka, Japan), 20% FCS
and 10% L-cell conditioned medium (L-cell CM) as a colony
stimulator (Worton et al., 1969), and continuously exposed
to drugs at various concentrations. Cultures were incubated
in 35mm Lux culture dishes (Miles Laboratories, Naperville,
Ill., USA) for 6 to 7 days at 37°C in a humidified
atmosphere of 5% CO2 in air. Colonies containing in excess
of 40 cells were scored with an inverted microscope. The
capacity for self-renewal of the blast cells (PE2) was
measured by the method of Buick et al. (1979) with minor
modification. Cell suspensions were prepared from culture
dishes containing the primary blast colonies. These were then
washed twice in a-MEM and plated at a concentration of
5x 103 cellsml-l in Linbro microwells (Flow Laboratories,
McLean, Va., USA) in 0.1ml a-MEM with 0.8% methyl-
cellulose, 20% FCS and. 10% L-cell CM. The cultures were
incubated for 7 days and colonies enumerated using an
inverted microscope.
Assay for granulocyte-macrophage colony (CFU-C)
formation Granulopoietic colony formation in culture by
CFU-C of RFM mouse was determined as previously
reported (Nara et al., 1984). Nucleated cells from femoral
marrow were plated at 105 cellsml-l in 1 ml McCoy's
modified 5A medium (GIBCO) supplemented with 0.8%
methylcellulose, 20% FCS and 10% L-cell CM. Cultures
were incubated for 7 days in a humidified atmosphere of 5%
CO2 in air. Granulocyte-macrophage colonies containing in
excess of 40 cells were counted. No secondary colony
formation (PE2) was observed.
Drug survival curves Sensitivities of leukaemic blast
progenitors and CFU-C to VCR, VDS and VP16 were
determined by continuous exposure to different quantities of
drugs. Drug survival curves were depicted as % survival of
colony formation.
Statistical evaluation Mean and standard deviation were
calculated for each point from the results of triplicate culture
plates. Negative exponential dose-responsive curves were
evaluated by linear regression analysis. D1O values (dose
required to reduce the number of colonies to 10% of
control) were determined from the slopes of the negative
exponential curves.
Cells of the M-3 cell line form colonies in semisolid
culture and also form secondary colonies by replating in
fresh medium. A statistically significant linear relationship is
seen between the numbers of cells plated in methylcellulose
culture and colony yield. Primary colony efficiency PEI was
729.6+88.94 per 5 x 103 plated cells, and secondary colony
plating efficiency PE2, 115.7+4.25 per 5 x 103 plated cells.
When M-3 cells were subcultured in suspension every 7th
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day, clonogenic cells showed exponential growth. PE2
determined at every subculture did not change. The
exponential growth of the clonogenic cells was considered to
be maintained by their self-renewal, and therefore PEI and
PE2 were thought to reflect the terminal and self-renewal
divisions, respectively. Although this cell line may not strictly
reflect the structure of in vivo human leukaemic
haemopoiesis, it can be useful as a model. Thus, we have
studied the effects of VCR, VDS, and VP16 on PEI and PE2
of these clonogenic cells. Figure 1 shows the dose-response
curves of VCR, VDS, and VP16 depicted as percent survival
of initial (PE1) and secondary (PE2) colony formation. Both
PEl and PE2 were suppressed by the drugs in a dose-
dependent manner, but PEI was more sensitive than PE2,
suggesting that VCR, VDS, and VP16 are effective on
terminal division of the clonogenic cells but not so effective
on their self-renewal capacity. From this point of view, these
agents may be used for the treatment of acute leukaemia in
combination with a drug that is known to inhibit the self-
renewal of blast progenitors, such as Ara-C (Buick et al.,
1981; Nara et al., 1986). To evaluate the antileukaemic
activities of these agents, we compared their effects on
leukaemic clonogenic cells and normal haematopoietic
precursors, CFU-C. The DIO values of the drugs for the
leukaemic cells (LCFU-C) and normal cells (NCFU-C) are
shown in Table I. Colony formation was more sensitive to
all three drugs in PE1 than in PE2 (D0 PEl <D0 PE2). A
sensitivity index, SI was obtained by dividing DO0 NCFU-C
by D1O LCFU-C. An SI value > 1 indicates a selective effect
Table I DIO values (pgml-1) for PEI and PE2 of M-3 cells
and for PEI of normal CFU-C, and sensitivity indices (SI) of
VCR, VDS, and VPl6
PEI PE2
DJO (gml-U') DJO (pgml-')
Agents LCFUC? NCFUCb SIC LCFUCa
VCR 0.038 0.124 3.263 0.073
VDS 0.053 0.066 1.245 0.147
VPl6 0.173 0.316 1.827 1.069
aLeukaemic CFU-C; bNormal CFU-C; CSI =DlO NCFU-
C/DlO LCFU-C.
of the drug on leukaemic colonies with less cytotoxicity on
normal CFU-C; the greater the value, the larger the
selectivity. Among the three drugs studied, VCR, had the
highest SI value and may be the most effective in the
treatment of acute leukaemia.
The cell line used in this study, judged as myeloblastic
leukaemia by morphological, cytochemical and cytogenetic
studies is considered a good model for human AML.
However, there may still be some disparity in the nature of
the murine and human disease. This type of study should be
undertaken in human AML to confirm the efficacy of these
drugs.
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Figure 1 The effects of continuous incubation with various concentrations of (a) VCR (PEl: r=0.984, PE2: r=0.999); (b) VDS
(PEI: r=0.835, PE2: r=0.774); (c) VP16 (PEI: r=0.995, PE2: r=0.995) on the survival of initial (-0 -)and secondary (-
0---) colony formation of M-3 cells. Each experiment was repeated 3 or 4 times.
References
BARLOGIE, B., SMITH, L. & ALEXANDIAN, R. (1984). Effective
treatment of advanced multiple myeloma refractory to alkylating
agents. N. Engl. J. Med., 310, 1353.
BUICK, R.N., MESSNER, H.A. & McCULLOCH, E.A. (1979).
Cytotoxicity of adriamycin and daunorubicin for normal and
leukaemia progenitor cells of man. J. Nall. Cancer Inst., 62, 249.EFFECT OF VCR, VDS AND VP16 ON LEUKAEMIA 519
BUICK, R.N., CHANG, L.J-A., MESSNER, H.A., CURTIS, J.E. &
McCULLOCH, E.A. (1981). Self-renewal capacity of leukemic blast
progenitor cells. Cancer Res., 41, 4849.
HAYATA, I., SEKI, M., YOSHIDA, K. & 4 others (1983). Chromosomal
aberrations observed in 52 mouse myeloid leukaemias. Cancer
Res., 43, 367.
KLIMO, P. & CONNORS, J.M. (1985). MACOP-B chemotherapy for
the treatment of diffuse large-cell lymphoma. Ann. Intern. Med.,
102, 596.
McCULLOCH, E.A., BUICK, R.N., CURTIS, J.E., MESSNER, H.A. &
SENN, J.S. (1981). The heritable nature of clonal characteristics in
tcutlc myeloblastic leukaemia. Blood, 58, 105.
NARA. N., JINNAI, I., IMAI, I., BESSHO, M. & HIRASHIMA, K.
(1984). Reduction of granulocyte-macrophage progenitor cells
(CFU-C) and fibroblastoid colony-forming units (CFU-F) by
leukemic cells in human and murine leukaemia. Acta. Haematol.,
72, 171.
NARA, N., CURTIS, J.E., SENN, D.L., TRITCHLER, D.L. &
McCULLOCH, E.A. (1986). The sensitivity to cytosine arabinoside
of the blast progenitors of acute myeloblastic leukaemia. Blood,
67, 762.
SAUTER, C., FEHR, J., FRICK, P., GMUER, J., HONEGGER, H. &
MARTZ, G. (1982). Acute myelogenous leukaemia: successful
treatment of relapse with cytosine arabinoside, VP16-213,
vincristine and vinblastine (A-Triple-V). Eur. J. Cancer Clin.
Oncol., 18, 733.
SMITH, S.D., TRUEWORTHY, R.C., KISPER, S.E., NOLLER, L.G. &
LOWMAN, J.T. (1983). In vitro sensitivity of normal granulocytic
and lymphoma colonies to vinca alkaloids. Cancer, 51, 417.
WORTON, R.G., McCULLOCH, E.A. & TILL, J.E. (1969). Physical
separation of hemopoietic stem cells from cells forming colonies
in culture. J. Cell. Physiol., 74, 171.